Introduction
G lioblastoma multiforme (GBM) is the most aggressive cancer that begins within the brain. The term GBM was introduced in 1926 by Percival Bailey and Harvey Cushing, based on the idea that the tumor originates from primitive precursors of glial cells (glioblasts) and the highly variable appearance due to the presence of necrosis, hemorrhage and cysts (multiform). It is the second-most common central nervous system cancer after meningiomas, which arise from the meninges. [1] Signs and symptoms of glioblastoma are initially nonspecific. They may include headache, personality changes, drowsiness, nausea, seizure, and symptoms similar to those of a stroke. Worsening of symptoms is often rapid and can progress to unconsciousness. GBM occurs more commonly in males over 50 years of age and mostly sporadic without any genetic predisposition. [2] The tumors are histopathologically characterized by features of hypercellularity, cellular polymorphism, brisk mitotic activity, microvascular proliferation, and necrosis. The small areas of necrotizing tissue are surrounded by anaplastic cells with the presence of hyperplastic blood vessels. [3] The cause of glioblastoma is unclear and represents 15% of brain tumors. [4] The diagnosis is typically made by a combination of computed tomography (CT) scan,
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Case Reports

Case 1
A 45-year-old female was admitted for irrelevant talks for the past 15 days with the complaints of vomiting, loose stool, and urinary incontinence. There was no history of any associated fever, seizure episodes, diabetes mellitus, hypertension, tuberculosis, or neurological diseases. On systemic examination, the patient was disoriented and had irrelevant talks. Blood pressure and pulse were within normal range. The physician did not find any systemic association, and we were called for routine fundus examination. Ophthalmological examination did not show any restriction in extraocular movements. Pupils were normal. Intraocular pressure was digitally normal, and vision could not be assessed. On fundus examination, there was gross papilledema in both eyes [ Figure 1 ]. On noncontrast CT (NCCT) brain, there was an inhomogeneous mass with a hypodense center and a variable ring of enhancement surrounded by edema in the frontal lobe [ Figure 2 ]. She was then referred to mainland for further management, where she underwent resection of the tumor. Histopathology confirmed the diagnosis of GBM with features of multinucleated tumor cells, prominent anaplasia, vascular proliferation, and palisading of tumor cells around necrosis with thickened vascular walls [ Figure 3 ]. She was discharged with temozolomide (75 mg/m 2 /day) and was planned for radiotherapy on the subsequent visit. Postsurgery her vision was 6/6 in both eyes without the development of any cranial nerve palsy. On subsequent follow-up, papilledema has reduced. She survived 5 months thereafter without any recurrence with temozolomide.
Case 2
A 60-year-old female presented with unresponsiveness for the past 4 days with generalized weakness and was admitted to the department of internal medicine. There was no history of any fever, loose stool, vomiting, cough, or urinary tract infection. She was suffering from on-off severe headache for the past 2 years often with vomiting and was initially treated as a case of migraine. She was a known case of Type II diabetes mellitus and was under oral hypoglycemic therapy for the past 10 years. Her normal random blood glucose level eliminated the diagnosis of hypoglycemia. She was treated as a case of sepsis but did not find any systemic association. On examination, her pupils were normal in size and pupillary light reflex was normal. On fundus examination, there was gross papilledema in both eyes [ Figure 4 ] and was advised for MRI brain. MRI brain sagittal view showed a frontal intraparenchymal solitary, poorly delineated large tumor with peritumoral edema and had signal heterogeneity suggestive of GBM [ Figure 5 ]. Subsequently, the patient was referred to neuro-oncologist at the mainland where she underwent resection of the tumor. Histopathological findings of hypercellularity, cellular polymorphism, brisk mitotic activity, microvascular proliferation, and necrosis confirmed the diagnosis of GBM. At discharge, her vision was 6/24 in both eyes with Grade-III cataract with persisting of papilledema. She was prescribed Temozolomide (75 mg/m 2 /day) with follow-up after 1 month. After 2 months, she again presented with severe headache and repeat MRI brain revealed recurrence of the tumor. She died after 3 months.
Case 3
A 50-year-old male patient was admitted to the department of internal medicine with the complaints of severe headache, vomiting, restlessness, and irrelevant talks. There was a history of on-off temporal headache with nausea and vomiting for the past 5 years and was treated as a case of migraine. His condition worsened despite the treatment. Systemic examination and laboratory investigations were normal. On ophthalmological examination, vision was 6/6 in both eyes. Intraocular pressure was digitally normal. There was no limitation in extraocular muscle movements. On fundus examination, there was gross papilledema in both eyes with peripapillary hemorrhages [ Figure 6 ] and was advised for NCCT brain with contrast. On NCCT brain, there was a space-occupying lesion in the frontal lobe [ Figure 7 ]. She was then referred to mainland where she underwent tumor resection and histopathology confirmed the diagnosis of GBM. She was discharged with Temozolomide (75 mg/m 2 /day) with follow-up after 1 month. At discharge, her vision was 6/12 unaided with persisting of papilledema. Thereafter patient was lost to follow-up.
Discussion
Glioblastoma are highly infiltrative tumors, and the primary one have a worse prognosis. The median survival time from the time of diagnosis without any 6 : Gross papilledema with peripapillary hemorrhages treatment is 3 months, but with treatment survival of 1-2 years is common. [8] In the present case series, two patients died within 5 months after tumor resection. Increasing age (>60 years of age) carries a worse prognostic risk. Death is usually due to widespread tumor infiltration with cerebral edema and increased intracranial pressure. [4] The diagnosis is typically made by a combination of CT scan, MRI scan, and tissue biopsy. [5] The cause of most cases is unclear. The treatment involves maximal surgical resection followed by partial-field external beam radiotherapy with concomitant temozolomide. [6, 7] All our patients underwent surgical resection followed by temozolomide therapy. Despite optimal therapy, glioblastoma invariably recur. [8] In our case series, only one case reported with recurrence after 2 months and the patient passed away before we send her to mainland for further management. The treatment for recurrent disease may include repeated surgery [9] and alternative chemotherapy regimens. [10] Conclusion A thorough ophthalmological examination is necessary in middle-aged patients presenting with symptoms of headache, drowsiness, nausea, vomiting, personality changes, and seizures. Presenting symptoms along with ocular findings such as papilledema may suggest a space-occupying lesion or underlying malignancy of the brain. Neuroimaging and/or biopsy of the intracranial mass are required to confirm the diagnosis.
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